ANDEMBRY

This brand name is authorized in Lithuania, United Kingdom

Active ingredients

The drug ANDEMBRY contains one active pharmaceutical ingredient (API):

1 Garadacimab
UNII 32W6AJL0DY - GARADACIMAB
Read about Garadacimab

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ANDEMBRY Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B06AC07 B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1102710, 1102711, 1102712, 1102713

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈